Buying a GLP-1 From Another Country: What US Rules Actually Say

A neutral, non-legal look at what US rules and safety systems say about importing GLP-1 medication from another country.

Maybe a friend brought a box back from a trip. Maybe an ad promised you the same shot for a fraction of the price if you order from a pharmacy overseas. It is a fair question, and a common one: can you legally buy a GLP-1 from another country and have it shipped to your door here in the US? This is not a how-to, and it is not legal advice. It is a plain look at what US rules and safety systems actually say, so you can make a decision with your eyes open.

What US rules actually say

Start with the baseline, because it surprises people. The FDA's position is that in most circumstances it is illegal for an individual to import a drug into the US for personal use. The reason is technical, but it matters. Medicines bought from other countries often have not been approved by the FDA for sale here, and even a foreign-labeled version of a drug that is approved in the US is treated as an unapproved product. So the box may look familiar. On paper, in this country, it is a different thing.

The personal-importation policy is discretion, not a green light

You may have heard that the FDA lets people bring in a small personal supply. There is a policy along those lines, but it is widely misread. It is enforcement discretion, decided case by case, not a legal right and not a safe harbor you can plan around. Historically the agency has allowed at most about a 90-day supply of an unapproved drug, and only when a set of conditions all line up at once:

• the drug treats a serious condition
• no effective treatment for that condition is available in the US
• the product poses no unreasonable risk
• a US-licensed physician is named as responsible for the care, or the medicine continues a treatment already started abroad

Every one of those has to be true. It is a narrow door, and it was built for a narrow situation.

Why weight-loss drugs do not fit that window

Here is the part that settles the question for most readers. FDA-approved semaglutide and tirzepatide products are available in the US. When an effective, approved treatment already exists here, the case-by-case exception, which hinges on a treatment not being available domestically, does not apply. The FDA has also said plainly that this policy was never intended as a way to bring in lower-priced prescriptions. It was meant to give access to therapies you cannot get here at all. Cost, on its own, is not the trigger.

There is a second wrinkle worth knowing. Reimporting a drug that was manufactured in the US, by anyone other than the original manufacturer, is not permitted even when the product would otherwise meet approval requirements. The reasoning is simple: once it has left the country and come back, no one can vouch for how it was stored or handled along the way.

Verification stops at the border

When you buy from a US-based pharmacy, you have real tools to check it. You can confirm a license with the state board of pharmacy. You can look for NABP's Buy Safely program and the .pharmacy seal, or LegitScript certification, and you can use the FDA's BeSafeRx guidance to locate a state-licensed online pharmacy. Here is the catch. Those systems are jurisdiction-bound. They stand behind sellers inside the US and other regulated markets. A website based in another country that ships to US patients sits outside a US state board's authority, so none of these tools can actually vouch for it, no matter what badges appear on the page. The scale is sobering: the FDA and NABP estimate that fewer than 3% of online "pharmacies" comply with state and federal law. For the longer version of how to size up a seller, read is online semaglutide safe and our walkthrough on verifying a pharmacy.

Counterfeit and cold-chain risk is not hypothetical

This is where a border question quietly becomes a safety question. In 2024 the World Health Organization issued a medical product alert on falsified Ozempic (semaglutide), with fake batches turning up in more than one country, including the US, and its surveillance has logged rising falsified-semaglutide reports across regions since 2022. The next year the FDA warned consumers not to use counterfeit Ozempic found in the US supply chain outside the manufacturer's authorized channel. A counterfeit is not one fixed thing. It can contain the wrong ingredient, too little active drug, too much, none at all, or something that has no business being there.

Then there is temperature. Injectable GLP-1s need refrigeration, and the FDA has received complaints of product arriving warm. A long international shipment is exactly the kind of trip where the cold chain breaks silently, with no way for you to see it after the fact. The FDA has also flagged that the active ingredient in unapproved GLP-1 products often comes from foreign suppliers that are unregistered and uninspected, sometimes labeled "for research use only." US regulators have stepped up import screening of non-compliant GLP-1 raw ingredients from unregistered foreign suppliers. That kind of measure targets bulk ingredient shipments, not your mailbox, so read it less as a rule about individuals and more as a signal of how closely the agency is watching material coming from abroad. To see what good documentation looks like, our pieces on medication quality and COA and spotting counterfeit GLP-1 go deeper.

"It is the same drug" leaves out the part that matters

It is tempting to assume a foreign box of the same brand is simply the same medicine at a better price. Legally, here in the US, it is not the same thing. A foreign-labeled product is unapproved in this country, and its counterfeit and cold-chain integrity cannot be assured once it has left a controlled supply chain. A quick note on the brands, since they come up: Ozempic and Wegovy are products of Novo Nordisk, and Mounjaro and Zepbound are products of Eli Lilly; New Hope Weight Loss and Wellness is not affiliated with either company. And if you are weighing this against a compounded option, keep the ground rules straight. Compounded semaglutide and tirzepatide are not FDA-approved and not brand-identical, and results vary by individual. None of that is a judgment on anyone's motives. It is just the reality of what does and does not survive a border intact.

A calmer way to weigh access

If cost or supply is what is pushing you to look abroad, that is worth taking seriously, and it is worth solving with someone who can actually be responsible for your care. A licensed US clinician or pharmacist can walk you through your real options here, including what is FDA-approved and what a legitimate compounded route looks like. Before you act on anything you read, including this, check the FDA's current official guidance at fda.gov, because the language changes over time and the agency's own page is the source of record. A GLP-1 is a long-term medication, not a one-time purchase. The goal was never just to get a vial through the door. It is to know, every single month, that what you are putting in your body is what the label says it is.

Frequently asked questions

This article is informational only and not medical advice. Speak with a licensed physician before starting or changing any GLP-1 therapy. Individual results vary. New Hope Weight Loss is a physician-supervised medical weight loss clinic in Costa Mesa, CA. Eligibility for treatment is determined during the medical consultation. Compounded semaglutide and compounded tirzepatide are not the same products as Wegovy®, Ozempic®, Mounjaro®, or Zepbound®.